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Background: One of the cardinal requirements for effective therapeutic management of tumors is the selective
delivery of cancer drugs to the right site by ligand-decorated nanomedicines. Screening of 2 × 109 clone landscape
phage library provides a reliable avenue for generating protein ligands specific for tumor cells. It was shown that
selective phage proteins derived from landscape phage libraries against breast and prostate cancer cells are able to
navigate drug or siRNA loaded liposomes to corresponding cancer cells with minimal toxicity to non-neoplastic
cells. In an alternative platform, glioma cell-specific phage proteins were used for assembling in vivo cancer-specific
phage-like particles, named ‘phagemid infective particles’ as targeted gene-delivery vehicles.
Methods: To extend the panel of anticancer cell phages, we have screened a 2 × 109 clone landscape phage
library f8/8 to select phage clones specific for metastatic prostate cancer cell PC-3M. The phage clones were
characterized for their selective interaction with PC-3M cells using phage capture assay, immunofluorescence
microscopy and electron microscopy. A prostate cancer selective phage was converted to phage-like particles
harboring emerald green fluorescent protein.
Results: Phage clone EPTHSWAT (designated by the sequence of inserted peptide) was found to be most selective
for PC-3M cells and was observed to internalize PC-3M cells as revealed by immunofluorescence microscopy and
electron microscopy. Conversion of this phage to phage-like particles harboring emerald green fluorescent protein
and the expression of emerald green fluorescent protein in the phage-like particles treated PC-3M cells showed
potential of adoption of this phage-like particle in prostate cancer therapeutic gene delivery.
Conclusion: Successful employment of phage-like particles expressing emerald green fluorescent protein genes
targeted to prostate cancer cells PC-3M confirms a prospect of their use for targeted delivery of therapeutic genes
to cancer cells.
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Prostate cancer is the second most frequently diagnosed
cancer amongst men in the US. An estimated 238,590
new cases are estimated to be diagnosed with an expected
death of 29,720 in men in the U.S in 2013 [1]. Conven-
tional treatment modalities based on surgery, radiotherapy
and chemotherapy have not ensured complete remission
of the disease, which would account for 28% incidence of
cancers of men in the U.S in 2013 [1]. Therefore, new con-
cepts of prostate cancer care, including therapeutic oligo-
and polynucleotides have been proposed as a promising* Correspondence: EisenstarkA@missouri.edu
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distribution, and reproduction in any mediumalternative [2]. However, a prerequisite for effective gene
therapy is specific delivery of therapeutic genes to a target
tissue and its sustained expression in the effected cancer
cells [3]. Current gene delivery approaches are based on
the use of viral and non-viral delivery systems. Non-viral
systems comprise naked DNA, or DNA associated with
polymers, dendrimers, liposomes, polyethylenimine, poly-
lysine, cationic peptides and, other non-infective vehicles.
While non-viral delivery systems assure safety and
modularity [4,5], they rank in efficiency of cell transduc-
tion below mammalian viral therapeutic oligonucleotides
delivery vesicles based on herpesviruses, retroviruses, ade-
noviruses, or adeno-associated viruses, which have been
evolved to acquire natural tropism for mammalian cells.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Phage clones generated from the second round







Phage clones are designated by the structure of the inserted (fused)
guest peptides.
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however can limit their use as therapeutics, since they can
readily infect both target tumor cells and non-related
healthy cells and can provoke fulminant immune re-
sponse. Thus, they require reengineering to extirpate their
natural tropism, re-target to specific tissues and make
them less immunogenic [6,7]. By contrast, filamentous
bacteriophages (phages) which are prokaryotic viruses,
possess no natural tropism for mammalian cells, yet can
be adapted to evolve tropism for target tumor cells by
fusion of their surface proteins with tumor-specific pep-
tides [8,9]. For example, phages with fusion peptides as
targeting ligands on the pIII proteins have been shown to
transduce mammalian cells with subsequent transgene de-
livery [10-13]. In another study, [14] developed phagemid
particles with epidermal growth factors fused to pIII to
transduce mammalian cells. Another type of display, with
fusion peptides displayed on all multiple copies of the
major coat protein pVIII can be even more advantageous
for cell transduction since the multivalent display
results in more strong binding of the phage to cellular
receptors due to avidity effect, which provokes receptor
dimerization and clustering [3,15,16]. Another type of
tumor selective phagemid gene-delivery vehicles known
as phagemid infective particle was designed by [17]
using a phagemid system. These particles, ~ 700 nm
long by ~10 nm in diameter, display tumor specific
pVIII or pIII–fusion peptides which encapsulate a for-
eign phagemid DNA harboring all genetic elements ne-
cessary for expression of transgenes in mammalian cells
[9]. Thus, the phage-targeted phagemid gene delivery
can be considered as a new to tumor management strat-
egy. In the light of this, we have screened a 1 × 109clone
landscape phage library to isolate metastatic prostate
cancer-specific phage clones. The penetration of the
most specific phage clone into mammalian cells was
studied using fluorescence and electron microscopy.
Thereafter, the phage clone was converted into phage-
like particles using the phagemid system and its PC-3M
cell-transforming activity was observed using emerald
green fluorescent protein marker.
Results and discussion
Selection of prostate cancer cell-interacting phage clones
and studying their selectivity towards the target cells
To generate peptides specific for prostate cancer cells,
landscape phage library with an octapeptide insert was
screened against the metastatic prostate cancer cell line
PC-3M involving two selection rounds. 18 clones were
randomly picked and the structures of the displayed
peptides were determined using PCR, sequencing and
translation of the DNA sequences into amino acids
using DNASTAR software (DNASTAR, Madison, WI)
(Table 1). Phage clone EPTHSWAT was the mostfrequently selected, occurring 8 times, while phage
clone GDIVTSNS occurred 7 times.
Selectivity of the two abundant prostate cancer-
specific phages EPTHSWAT and GDIVTSNS towards
PC-3M cells were studied in a phage capture assay
(Figure 1). Selectivity assay is based on interaction of
phage particles with PC-3M cells in comparisons with
other cells RWPE-1 (non-neoplastic prostate cells), HT-
29 (human colon carcinoma cells) and serum. As seen in
Figure 1, phage EPTHSWAT showed more selective inter-
action with PC-3M cells with 14.4 fold greater interaction
than the phage GDIVTSNS and 35.1 fold greater than
the non-relevant control phage VPEGAFSS. Further-
more, phage EPTHSWAT showed a statistically significant
higher interaction with PC-3M cells than with other cells
RWPE-1, HT-29 and serum. This high interaction of the
phage particles with PC-3M cells might be due to phage
interaction with overexpressed macromolecules on the
surfaces of the cells.
Selective interaction of phage EPTHSWAT in a co-culture
with PC-3M, RWPE-1 and HT-29 cells
To further confirm the selective interaction of phage
EPTHSWAT with PC-3M cells;PC-3M, RWPE-1 and
HT-29 cells were co-cultured and incubated with phage
EPTHSWAT for 1 h at 37°C. Phage was fluorescent
labeled with antibodies and observed by fluorescence
microscopy.
We observed that majority of the phage particles local-
ized in PC-3M cells with very scanty amount in RWPE-1
and HT-29 cells. As shown in Figure 2, the predominant
interaction of the phage particles with PC-3M cells is aus-
picious for harnessing the phage peptides to navigate ther-
apeutics to the desired site of lesion with minimal
bystanders’ effect.
The selective interaction of phage EPTHSWAT with
PC-3M cells in comparison with the non-relevant phage
VPEGAFSS at 15 min or 1 h was also studied (Figure 3).
At 15 min post incubation, phage EPTHSWAT was
already interacting with PC-3M cells while the control
phage particles were washed away during the washing
stage of the procedure. At 1 h post-incubation, a great
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Figure 1 Selectivity of the phage clones EPTHSWAT and GDIVTSNS toward target cells PC-3M in comparison with other cells (non-
neoplastic prostate epithelial cells, RWPE-1; colon adenocarcinoma cells, HT-2A) and serum. Panel A depicts levels of interaction of phage
EPTHSWAT with PC-3M cells, RWPE cells, HT-29 cells and serum; Panel B shows the levels of phage GDIVTSNS interaction with PC-3M cells, RWPE
cells, HT-29 cells and serum. Selectivity was estimated as phage recovery (%) = output (cell-associated) phage/input phage. Unrelated phage
bearing the guest peptide VPEGAFSS was used as a control.
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internalized by PC-3M cells whereas very scanty control
phage particles were observed interacting with the cells.
The interaction of phage EPTHSWAT with the cells at
the two time points were specific because phage particles
still interacted with the cells despite stringent washing
steps employed in the procedure. This is also evidenced by
the washing away of majority of the control phage parti-
cles bound to the cells through non-specific interactions.
Tracking phage EPTHSWAT interaction with PC-3M cells
Immunogold electron microscopy was employed to pre-
cisely track the kinetics of phage EPTHSWAT interac-
tions with PC-3M cells in comparison with the control
phage VPEGAFSS.Phage EPTHSWAT was incubated with
PC-3M cells at three time points 15 min, 1 h or 24 h. As
seen in Figure 4, at 15 min post-post incubation, phage
EPTHSWAT particles had already bound to the surfaceFigure 2 Immunofluorescence microscopic demonstration of phage c
PC-3M, RWPE-1 and HT-20 cells. White arrows point PC-3M (prostate can
Phage EPTHSWAT intra-cytoplasmic and nuclear localization at 1 h post-inc
stained with goat anti-rabbit Alexa Fluor 488 were revealed as abundant g
particles in HT-29 cells. The control uninfected co-culture showed no greenof the cells and some had gain entry into the cytoplasm,
whereas, the control phage particles were not observed
interacting with the cells.
The binding and internalization of phage EPTHSWAT
particles at this time point corroborates the previously
described results of immunofluorescence tracking of
phage interaction with PC-3M cells. This further revealed
the selective interaction of the test phage interacting with
PC-3M cells in comparison with the control phage.
Absence of the control phage particles interacting with
PC-3M was as a result of the washing step in the proced-
ure whereby non-specific interacting phage particles were
washed off. The internalization of phage EPTHSWAT into
the cytoplasm at 15 min post-incubation might be applic-
able for harnessing the phage fusion peptides for rapid
targeted delivery of therapeutics. Based on the binding
and internalizing of the test phage at 15 min post-
incubation, it could be inferred that the phage mechanismlone EPTHSWAT selectivity towards PC-3M cells in a co-culture of
cer) cells whereas red arrows point to HT-29 (colon cancer) cells.
ubation with the co-culture of PC-3M and HT-20 cells. Phage particles
reen spots in PC-3M cells in comparison with the very scanty phage
spots.
Figure 3 Immunofluorescence microscopic demonstration of phage clone EPTHSWAT interaction with PC-3M cells at two time points
15 min or 1 h in comparison with the control non-relevant phage VPEGAFSS. Phage particles were revealed as green spots and linear
particles in the cytoplasm and nuclei of the cells at 40X and 100X magnification of the objective lens at 15 min and 1 h post-incubation,
respectively.
Fagbohun et al. Journal of Nanobiotechnology 2013, 11:31 Page 4 of 10
http://www.jnanobiotechnology.com/content/11/1/31of entry into PC-3M cells is not through endocytic path-
way. This is also supported by the fact that the length of
the phage particle (1 μm) will not fit into the membrane
pits 700 nm in depth [18].
Generation of phage-like particles
To generate phage-like particles, K91 blue E. coli cells
were transformed with pcDNA™6.2-GW/EmGFP-miR vec-
tor encoding emerald green fluorescent protein (EmGFP).
The phagemid encodes EmGFP under the control of a
Pol II human CMV (cytomegalovirus) promoter and
Herpes simplex virus (HSV) thymidine kinase (TK)
polyadenylation signal; f1, pUC and SV40 origins of rep-
lication; spectinomycin (aadA1) and blasticidin (bsd) re-
sistance genes. The phagemids were rescued with phage
EPTHSWAT (helper phage) as illustrated (Figure 5).
Transmission electron microscopic imaging and
quantification of phage-like particles and phage
Transmission electron microscopy (TEM) was employed
to visualize the mixture of phage-like particles and phage
EPTHSWAT, quantify the particles and estimate their
lengths. As anticipated, some phage EPTHSWAT were
produced along with the phage-like particles but the
number of phage-like particles superseded that of the
phage particles due to the vector low copy number and
defective assembly of the phage particles created by dis-
ruption of the origin of the minus-strand synthesis with
the insertion of the Tn10 fragment [19]. The number of
phage-like particles on the electron microscopic field
was 59 whereas the phage particles were36; therefore the
molecular ratio of phage-like particles to the phages is
1.6 as shown (Figure 6).Virions/ml = (A269 (6 × 10
16)/ nucleotides in the gen-
ome, where A269 represents an absorbance at 269 nm
[20]. Therefore, for phage-like particles with the genome
size 5759 nucleotides, 1 AU269=1.04 × 10
13 virions/ml
whereas for the phage EPTHSWAT with genome size
9198 nucleotides, 1 AU269=6.5 × 10
12 virions/ml. The
molecular ratio of phage-like particles to phage particles
is 1.6, as determined by TEM (Figure 6). Thus their mass
ratio is (5759 × 1.6)/9198 = 1. Thus, 1 AU269 of preparation
contains 0.5 × 1.04 × 1013= 5.2 × 1012 virions/ml of phage-
like particles and 0.5 × 6.5 × 1012 = 3.25 × 1012 virions/ml
of phage particles. The phage-like particle is about 2/3rd the
size of the phage, since the calculated length of the phage-
like particle is 843 nm [(1.435 Ǻ X 5759) + 175 Ǻ] and that
of phage EPTHSWAT is 1337 nm [(1.435 Ǻ X 9198) +
175 Ǻ] [21] as confirmed (Figure 6).in vitro expression of emerald green fluorescent protein
gene
To track the expression of expression of emerald green
fluorescent protein gene in the phage-like particles;
phage-like particles in combination with the phage
were incubated with PC-3M cells at 37°C for 48 h while
cells incubated with phage only served as the control.
Cells were washed with PBS, fixed and visualized by
epifluorescence microscopy. As seen in Figure 7, some
cells incubated with phage-like particles and phage
demonstrated emerald green fluorescent protein ex-
pression as revealed by the green fluorescence when
observed with FITC filter of the epifluorescent micro-
scope (1A) whereas no fluorescence was observed with
the control (2A).
Figure 4 Electron micrographs of thin sections of phage EPTHSWAT–PC-3M cells and the control phage VPEGAFSS–PC-3M cells
interactions. The localization of phage particles is revealed by the presence of gold particles in the red circles. At 15 min post-incubation, a lot
of phage EPTHSWAT particles had bound and internalized PC-3M cells whereas phage VPEGAFSS had been washed off. At 1 h post-incubation,
more phage EPTHSWAT particles were seen internalizing PC-3M cells than the control phage. At 24 h post-incubation, more EPTHSWAT particles
had internalized and homed into the nucleus in comparison with the control phage.
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In this study, we demonstrated that screening of a 2 × 109
landscape phage library against metastatic prostate cancer
cell PC-3M allows isolating highly selective prostate can-
cer cell-specific phage, which can be readily converted into
a phage-like particle transducing the mammalian prostate
tumor with the potential to deliver therapeutic genes and
their expression products to cancer cells leaving normal
cells unscathed. Notwithstanding, the procedure was car-
ried in vitro and peptide selectivity to towards prostate
tumor has not been tested in vivo; the peptides generated
from the screening procedure might home tumor cellswhen tested in vivo based the stringent steps involved in
the selection procedure. Furthermore, peptides generated
from screening landscape phage library proffers avidity
effect based on multivalency that can arouse receptor
dimerization and clustering [3,15,16] in comparison with
commonly screened p-III fusion libraries with affinity
features. The delivery and expression of emerald green
fluorescent protein was revealed by visualization of green
fluorescence observed in some of the treated PC-3M cells.
Although the expression of the reporter gene EmGFP was
not high; this could have been improved if adeno-
associated virus inverted terminal repeats were present in
Figure 5 Schematic representation of the rescue of prostate cancer specific phage-like particles by the prostate cancer-specific helper
phage EPTHSWAT in E. coli. The blue arrows indicate the replication cycle of the helper phage generating proteins needed for replication and
encapsidation of the phagemid, whereas, the maroon arrows show the replication and rescue of phage-like particles. The dotted lines indicate
the translocation of the helper phage expressed proteins to the inner membrane where they are involved in assembly. pV binds ss DNA whereas
pII nicks ds DNA and pX acts as inhibitor of pII function.
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this study can pave a way for developing highly efficient
transgene or oligonucleotides delivery systems against
other maladies aside cancer. Screening of landscape phage
libraries provides an effective way for development of
highly selective ligands to a variety of cell receptors and
their easy conversion into non-pathogenic phage-like par-




All cell lines were purchased from the American Type
Culture Collection (ATCC, Manassas, VA, USA).Cell line
PC-3M was employed as the target cell, whereas WI-38
(CCL-75) normal human lung fibroblasts were used for
depletion of phage library. Cells were cultivated in 25 cm2
cell culture flasks (Corning Inc., Corning, NY) containing
their respective media with L-glutamine (Sigma-Aldrich,
St. Louis, MO) supplemented with 10% fetal calf serum
(FCS) at 37°C in 5% CO2 cultivated.Phage display library
The landscape phage library f8/8 containing 2 × 109
clones [22] was screened to isolate clones binding target
prostate cancer cell lines. All procedures for handling
phages, including propagation, purification, titering,
isolation of phage clones, and isolation of phage DNA
have been described [23]. Escherichia coli (E. coli) strain
K91Blue {Hfr C thilacZΔ M15 lac Y::mkh lacIQ} used
for propagating phages was kindly provided by George
Smith [24].
Selection of prostate cancer cell-interacting phage clones
Screening of the phage library against PC-3M target cells
was run in T-25 cell culture flask. Briefly, an aliquot of
the phage library containing 100 billion phage particles
in serum-free medium was incubated in an empty cell
culture flask at 37°C for 1 h to deplete phage particles
binding plastic. Unbound phages recovered from the de-
pletion were incubated with pre-incubated serum in cell
culture flask at 37°C for 1 h to deplete phage particles
binding serum. Thereafter, unbound phage particles
Figure 6 Negative contrast electron micrograph of phage-like particles and phage EPTHSWAT. The phage-like particles are numbered in
red whereas the phage particles are in blue. The number of phage-like particles on the shown field is 59 whereas the phage particles are 36,
therefore the ratio of phage-like particles to the phages is 1.6. The phage-like particle is about 2/3rd the size of the phage (Inset).
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to deplete phage particles interacting with fibroblasts.
Unbound phages were removed, added to the target cells
and incubated at 37°C for 1 h. Subsequently, unbound
phages were discarded and cells were washed ten times
with washing buffer (0.1% BSA, 0.1% Tween 20 in serumFigure 7 in vitro transduction of phage-like particles and expression o
particles and phage at 37°C for 48 h and then observed with FITC filter epi
incubated with phage particles only and observed with FITC filter epifluorefree medium) to remove any remaining unbound phage
particles. Targeted cell-bound phage particles were eluted
with elution buffer (0.1 M glycine-HCl, pH 2.2) for 10 min
on ice and neutralized with 1 M Tris–HCl (pH 9.1). Phage
particles in eluate were concentrated in Amicon ultra-4
concentrators as recommended by the manufacturerf EmGFP. A1 and B1 represent PC-3M cells incubated with phage-like
fluorescence and bright field, respectively. A2 and B2 show cells
scence and bright field, respectively.
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rounds of selection but with no depletion steps. The
amplified eluate was as input in further rounds of se-
lection. These procedures were similar to the procedure
described above but with the exclusion of the depletion
steps depletion steps. Two rounds of selection were
performed. In each round, the enrichment of phage parti-
cles binding to the cells was determined by titering of in-
put and output phages. The ratio of output to input
phage increased from one round to another indicating
successful selection of phage clones interacting with the
target cell lines.
Testing of phage clones for selectivity towards prostate
cancer cells
PC-3M cell-specific phage clone EPTHSWAT was char-
acterized for their selectivity toward target prostate can-
cer cell PC-3M in comparison with control cells RWPE
(non-neoplastic prostate epithelia), HT-2A (colon car-
cinoma) and serum in a phage capture assay. Briefly,
target cells PC-3M, and control RWPE and HT-2A cells
were cultivated in triplicate to confluence in separate
wells of 96-well cell culture plates. The medium with
serum was incubated in separate wells in triplicate as a
control. Cells incubated with serum-free medium at
room temperature for 1 h were incubated with phage
(1 × 106 cfu) at room temperature for 1 h. Unbound
phages were carefully removed and cells were washed
with 100 μl washing buffer for 5 min eight times to re-
move non-interacting phages. Cells were lysed with 25 μl
lysis buffer (2.5% CHAPS) for 10 min on a shaker. The
lysate containing cell-interacting phages were titered in
E. coli. Phage recovery was calculated as the ratio of
output phage to input phage. An unrelated phage with
non-relevant guest peptide VPEGAFSS was used as the
control (Figure 1).
Immunofluorescence analysis of the selectivity of phage
EPTHSWAT towards PC-3M cells
PC-3M, HT-29 and RWPE cells were co-cultured in
Lab-Tek™ 4-well chamber slides (Thermo Scientific,
Rochester, NY) until they were 60% confluent. Subse-
quently, the cells were incubated with 1 × 1011 phage
particles in RPMI 1640 medium for 1 h at 37°C while
the other cells served as the uninfected controls. There-
after, cells were washed with PBS (pH 7.4), fixed in 4%
paraformaldehyde for 10 min, permeabilized with 0.25%
Triton X-100 (Sigma, St. Louis, MO) in PBS for 10 min
and blocked with 5% goat serum (MP Biomedicals,
Solon, OH) for 1 h. Cells were treated with 1:1000 dilu-
tion of 5 mg/ml rabbit anti-fd bacteriophage antibodies
(Sigma-Aldrich, St. Louis, MO) for 1 h, washed and
incubated with 1:500 AlexaFlour® 488 anti-rabbit IgG,
0.022 μM Alexa Flour® 546 phalloidin (Molecular Probes,Carlsbad, CA) for 1 h. Subsequently, cells were washed
three times with PBS and covered with VECTASHIELD
mounting medium with DAPI (Vector Laboratories,
Burlingame, CA). Images were acquired in grayscale
with a 12-bit digital camera coupled to Olympus BX51
microscope (Olympus, USA) equipped with bandpass
emission fluorescence filter optical blocks. During the
processing stage, individual image channels were
pseudocolored with RGB values corresponding to each
of the fluorophore emission spectral profiles with the
exception of Alexa Flour® 546 phalloidin, which was
pseudocolored red (Figure 2). Interaction of phage
EPTHSWAT with PC-3M cells in comparison with the
non-relevant phage VPEGAFSS was used to further con-
firm the selectivity of phage EPTHSWAT towards PC-
3M cells. 1 × 1011 phage EPTHSWAT and phage
VPEGAFSS were incubated with their corresponding
confluent PC-3M cells at 37°C for 15 min or 1 h and
processed as described previously and images were ac-
quired with the Olympus BX51 microscope (Figure 3).
Immunogold electron microscopic analysis of the
selectivity of phage EPTHSWAT towards PC-3M cells
PC-3M cells were seeded into Thermonax cover slips
(Thermo Scientific, Rochester, NY) and grown until con-
fluence. 1 × 1011 of phage EPTHSWAT particles were
incubated with cells at three time points: 15 min, 1 h or
24 h at 37°C. For the 24 h incubation, cell culture
growth medium was replaced with new growth medium
at 1 h post-incubation to remove unbound phage parti-
cles and cells were thereafter incubated for 24 h. The
non-relevant phage VPEGAFSS served as the negative
control. At the end of incubation for the three time
points, cells were washed thrice with PBS to remove un-
bound phage particles, fixed in 2% paraformyladehyde,
1% glutaraldehyde in 0.1 M cacodylate, pH 7.4., post-
fixed in 1% tannic acid (Electron Microscopic Sciences,
Hatfield, PA), dehydrated in ethanol and infiltrated and
embedded in LR White resin (Electron Microscopic
Sciences, Hatfield, PA). Ultrathin sections were cut on
formvar-carbon coated nickelgrids and labeled as de-
scribed [25] with 1:50 rabbit anti-fd bacteriophage IgG
(Sigma-Alrich, St. Louis, MO) and 1:5 goat anti-rabbit
conjugated with 10-nm gold particles. Grids were rinsed
and post-stained with 0.5% aqueous uranyl acetate.
Samples were observed in Joel 1400 electron micro-
scope operated at 80 kV.
Generation of phage-like particles
pcDNA™6.2-GW/EmGFP-miR vector was used to trans-
form electrocompetent K91 blue E. coli and transformants
were selected on NZY plates containing 50 μg/ml spec-
tinomycin grown at 37°C for 16 h. Transformants were
picked and propagated in 2 ml NZY media containing
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overnight. Subsequently, 300 μl overnight cultures was
added to 20 ml of NZY plates containing 50 μg/ml spec-
tinomycin and grown at 37°C in a shaking incubator at
200 rpm until the OD reached 0.450 at 600 nm. There-
after, the culture was inoculated with 1.0 × 109 colony
forming units (cfu) of the prostate cancer-selective
phage EPTHSWAT and incubated at 37°C for 15 min at
50 rpm for the phage to infect the E. coli. Then, 0.2 μg/ml
of tetracycline was added to the culture and incubated at
37°C for 40 min at 200 rpm. Following, tetracycline was
added to 20 μg/ml and the culture was grown overnight.
Finally, the phage-like particles preparation were collected
by two successive polyethylene glycol 8000 precipitations
and suspended in 100 μl Tris buffered saline (TBS; 50 mM
Tris–HCl, pH 7.5 and 150 mM NaCl).Transmission electron microscopic imaging and
quantification of phage and phage-like particles
6 μl of a mixture of phage-like particles and phage
were dispensed on a carbon film coated copper grid
(Electron Microscopic Sciences, Hatfield, PA) and in-
cubated for 5 min at room temperature. The mixture
was tipped off and the grid was stained with a drop of
5% uranyl acetate for 5 min at room temperature. The
stain was tipped off and the grid was allowed to dry for
5 min and observed in Joel 1400 electron microscope
operated at 80 kV. The quantities and ratio of phage-like
particles and phage in the preparation were determined
by counting their numbers in a field of view as depicted
(Figures 6 and 7).in vitro expression of emerald green fluorescent protein
To test the expression of emerald green fluorescent pro-
tein in PC-3M cells, 8.0 × 1010 phage-like particles with
5.0 × 1010 phage EPTHSWAT were incubated with con-
fluent PC-3M cells in the well of a Lab-Tek™ 4-well
chamber slide (Thermo Scientific, Rochester, NY) for 48
h at 37°C while cells incubated with only 5.0 × 1010
phage EPTHSWAT served as the control. Cells were
washed three times with PBS, fixed, visualized and im-
aged under Olympus BX51 microscope (Olympus, USA)
with FITC emission fluorescence filter and bright field
(Figure 7).
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